ArticleBMC gastroenterology2024

Integrin β5, a noninvasive diagnostic biomarker, is associated with unfavorable prognosis and immunotherapy efficacy in gastric cancer.

Yangyang Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.